CYTOGENETIC CHARACTERIZATION OF CHRONIC MYELOID LEUKEMIA AND ITS PROGNOSTIC IMPACT UPON TREATMENT WITH TYROSINE KINASE INHIBITORS

被引：0

作者：

Canamero, Giro Eloi ^{[1
]}

Garcia, Olga ^{[1
]}

Boque, Concepcion ^{[2
]}

Sitges, Marta ^{[3
]}

Vallansot, Rolando Omar ^{[4
]}

Cisneros, Adela ^{[1
]}

Cortes, Montserrat ^{[5
]}

Gener, Georgina ^{[6
]}

Vela, Dolors ^{[7
]}

Font, Llorenc ^{[8
]}

Pineda, Alberto ^{[9
]}

Xandri, Marisol ^{[1
]}

Santafe, Encarnacion ^{[1
]}

Espasa, Andrea ^{[1
]}

Comes, Martina ^{[1
]}

Xicoy, Blanca ^{[1
]}

Zamora, Lurdes ^{[1
]}

Granada, Isabel ^{[1
]}

Navarro, Jose Tomas ^{[1
]}

Grau, Javier ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Inst Catala Oncol, Inst Recerca Leucemia Josep Carreras, Barcelona, Spain

[2] ICO Hosp Duran & Reynals, Lhospitalet De Llobregat, Spain

[3] ICO Hosp Univ Josep Trueta, Girona, Spain

[4] Hosp Univ Joan XXIII, Tarragona, Spain

[5] Hosp Granollers, Granollers, Spain

[6] Hosp Mataro, Mataro, Spain

[7] Hosp Mollet del Valles, Mollet, Spain

[8] Hosp Verge de la Cinta, Tortosa, Spain

[9] Hosp Esperit St, Santa Coloma, Spain

来源：

HAEMATOLOGICA | 2020年 / 105卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PO-057

引用

页码：169 / 170

页数：2

共 50 条

[31] Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
Gale, Robert Peter
Goldman, John M.
ACTA HAEMATOLOGICA, 2013, 130 (03) : 192 - 195
[32] Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia
Shima, Haruko
Kada, Akiko
Tanizawa, Akihiko
Sato, Iori
Tono, Chikako
Ito, Masaki
Yuza, Yuki
Watanabe, Akihiro
Kamibeppu, Kiyoko
Uryu, Hideko
Koh, Katsuyoshi
Imai, Chihaya
Yoshida, Nao
Koga, Yuhki
Fujita, Naoto
Saito, Akiko M.
Adachi, Souichi
Ishii, Eiichi
Shimada, Hiroyuki
PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
[33] The Association of Tyrosine Kinase Inhibitors with Obesity in Chronic Myeloid Leukemia
Rajan, Raeesha
Karia, Esha
Samaan, M. Constantine
Balakumaran, Janatani
Golemiec, Breanne
Spatafora, Laura
Banfield, Laura
Athale, Uma
Thabane, Lehana
Fleming, Adam
Samaan, Constantine
OBESITY, 2021, 29 : 172 - 172
[34] Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia
Campiotti, Leonardo
Bolzacchini, Elena
Sutter, Matteo Basilio
Maresca, Andrea Maria
Grandi, Anna Maria
Guasti, Luigina
INTERNAL AND EMERGENCY MEDICINE, 2018, 13 (08) : 1337 - 1339
[35] Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children
Phillips, Lia N.
Hijiya, Nobuko
PEDIATRIC DRUGS, 2021, 23 (03) : 241 - 251
[36] The Impact of Tyrosine Kinase Inhibitors on Chronic Myeloid Leukemia Stem Cells and the Implication in Discontinuation
Jiang, Lin
Wang, Hongxiang
Zhu, Xiaoying
Liu, Wen
Zhou, Shu
Geng, Zhe
Xiao, Yi
Zou, Ping
You, Yong
Li, Qing
Zhu, Xiaojian
STEM CELLS AND DEVELOPMENT, 2019, 28 (22) : 1480 - 1485
[37] The Applicability of Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia
Ata, Fateen
Ghasoub, Rola
Benkhadra, Maria
Fernyhough, Liam
Aldapt, Mahmood
Omar, Nabil E.
Nashwan, Abdulqadir
Mushtaq, Kamran
Yassin, Mohamed A.
BLOOD, 2023, 142
[38] A safety review of tyrosine kinase inhibitors for chronic myeloid leukemia
Ozmen, Deniz
Alpaydin, Duygu Demet
Saldogan, Muhammed Ali
Eskazan, Ahmet Emre
EXPERT OPINION ON DRUG SAFETY, 2024, 23 (04) : 411 - 423
[39] Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children
Lia N. Phillips
Nobuko Hijiya
Pediatric Drugs, 2021, 23 : 241 - 251
[40] The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Pophali, Priyanka A.
Patnaik, Mrinal M.
CANCER JOURNAL, 2016, 22 (01): : 40 - 50

← 1 2 3 4 5 →